Niva Bupa Health Insurance Company Limited has informed the Exchange regarding 'Reporting of sale of shares'.

Ownership Changes View source PDF Explain this filing

NIVABUPA · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

-0.3%Reaction day

₹83.31

prior close

₹83.64

announcement price

After-mkt

timing

Nifty Smallcap 250market · index membership as recorded later (tracked since Jun 2026)+0.5%-0.8% vs market

General Insurance peers, median of 5sector+0.5%-0.8% vs sector

On the reaction day the stock moved 0.8 pts less than Nifty Smallcap 250 and 0.8 pts less than its General Insurance peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

-1.1

10m

-1.6

15m

-1.7

30m

-1.9

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

-0.3+0.5-0.8+0.5-0.8

Next day

-0.6+1.2-1.8+1.0-1.6

-0.4+1.9-2.3+4.3-4.7

+0.2+3.2-3.0+4.3-4.2

-0.6+3.4-4.0+4.6-5.3

-0.8+3.3-4.1+4.2-5.0

-2.0+1.4-3.4+1.5-3.5

15d

-1.5+2.9-4.4+3.0-4.6

+1.8+4.7-2.8+1.0+0.8

-1.6+0.3-1.9+1.9-3.4

-1.6-0.6-0.9+0.8-2.4

UpDownMarket · Nifty Smallcap 250Sector · General Insurance peers, median of 5Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Mr. Krishnan Ramachandran, Managing Director and CEO of Niva Bupa, sold 1,00,00,000 (1 crore) equity shares on June 2, 2025, as disclosed under SEBI's Prohibition of Insider Trading Regulations. The proceeds from this sale are intended to enable the exercise of his ESOPs and to cover the perquisite tax on them. He has exercised 1,03,74,960 ESOPs, with corresponding shares to be allotted in due course. The disclosure was made to the NSE and BSE by the Company Secretary on June 3, 2025.

Likely market impact

This is a routine insider trading disclosure where the CEO is selling a portion of his holdings to fund ESOP exercise and related taxes, not a signal of weak conviction in the company. Shareholders should note that ESOP allotment from the exercise will slightly increase the total share count, leading to minor dilution.